Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | HEG1 |
| Upstream (Parents) |
|---|
| (<<) DCN → HEG1 |
| (<<) LHFP → HEG1 |
| (<<) ENTPD1 → HEG1 |
| (<<) PTRF → HEG1 |
| Downstream (Children) |
|---|
| HEG1 → PLK2 (>>) |
| HEG1 → DCN (>>) |
| HEG1 → SPARCL1 (>>) |
| HEG1 → CILP (>>) |
| HEG1 → RARRES1 (>>) |
| HEG1 → FHL1 (>>) |
| HEG1 → SP3P (>>) |
| HEG1 → CYR61 (>>) |
| HEG1 → PRTN3 (>>) |
| HEG1 → TRIL (>>) |
| HEG1 → IGFBP5 (>>) |
| HEG1 → PDE10A (>>) |
| HEG1 → TUSC3 (>>) |
| HEG1 → AKAP6 (>>) |
| HEG1 → FKBP6 (>>) |
| HEG1 → TCF4 (>>) |
| HEG1 → PEX16 (>>) |
| HEG1 → LIMCH1 (>>) |
| HEG1 → EML1 (>>) |
| HEG1 → PLXND1 (>>) |
| HEG1 → LRRC32 (>>) |
| HEG1 → ADA (>>) |
| HEG1 → TGFB3 (>>) |
| HEG1 → RTN1 (>>) |
| HEG1 → PTPRM (>>) |
| HEG1 → LTBP3 (>>) |
| HEG1 → GAS6 (>>) |
| HEG1 → ARHGEF6 (>>) |
| HEG1 → RPL21P68 (>>) |
| HEG1 → RPS6KA2 (>>) |
| HEG1 → SLC12A8 (>>) |
| HEG1 → CALHM2 (>>) |
| HEG1 → PKD2 (>>) |
| HEG1 → DGKE (>>) |
| HEG1 → BMP1 (>>) |
| HEG1 → TP53TG3B///TP53TG3 (>>) |
| HEG1 → PTRF (>>) |
| HEG1 → ICAM2 (>>) |
| HEG1 → SSBP2 (>>) |
| HEG1 → VEGFC (>>) |
| HEG1 → MTMR9 (>>) |
